Avalyn Pharma Inc. Common Stock
Status: Publicly traded
Direct answer
Avalyn Pharma Inc. Common Stock is publicly traded on NASDAQ under the ticker AVLN.
Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
Can you invest in Avalyn Pharma Inc. Common Stock?
Yes. Avalyn Pharma Inc. Common Stock trades publicly on NASDAQ as AVLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Avalyn Pharma Inc. Common Stock
Detailed equity research is provided by MarketSnap.